According to press reports, specialists of the SemBioSys Genetics institution, placed the insulin producing gene in safflower seeds, a vegetable also named carthamus, used commonly to obtain oil.

Andrew Baum, executive of that organization, explained that the plant must grow for the gene to be activated and for the seed to produce the insulin, which must be soon harvested and purified.

Once in operation, this method will harness the production of greater volumes of this valuable substance, which is presently obtained by means of an expensive process of bacteria fermentation in deposits.

Some optimists' consider the possibility and predict that production costs would decrease by 70 percent and the acquisition costs possibly by 40 percent or more.

The Canadians trust that their technology can satisfy the world-wide insulin demand.

In the planet, near 180 million people suffer from diabetes, number that could duplicate towards 2030, in agreement with statistics of the World Health Organization.

In addition, there are millions of people considered dependent of insulin medication, according to the type of diabetes that suffer generally II, the most severe one.

Considered initially a flagellum of the poor or developing countries, the developed world sees the increase in the number of the affected, influenced by the rise in obesity, hypertension and non-healthful diets, rich in polyunsaturated fats.

The Canadian scientific contribution must now go through animal tests'.